AEON Biopharma, Inc. (AEON) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for AEON Biopharma, Inc. (AEON).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.698

Daily Change: -$0.0131 / 1.87%

Daily Range: $0.691 - $0.731

Market Cap: $8,064,141

Daily Volume: 62,781

Performance Metrics

1 Week: -1.92%

1 Month: -12.80%

3 Months: 44.39%

6 Months: -92.38%

1 Year: -99.14%

YTD: -98.17%

Company Details

Employees: 5

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.

Selected stocks

S&P 500 ETF (SPY)

NASDAQ 100 ETF (QQQ)

Gold ETF (GLD)